Although there were no associations between several clinicopathological factors and FilGAP expression, the OS of stage I–IV and/or III/IV patients with FL or GCB-type DLBCL showing high FilGAP scores were significantly poorer than that of FilGAP-negative tumors according to the Kaplan–Meier survival curves. This evidence concerns the gene ARHGAP24 and diffuse large B-cell lymphoma.